Evaluation of the satisfaction and experiences of oncology patients and doctors using teleconsultation during the COVID-19 pandemic.

Autor:	Kastrisiou M; Medical Oncology Department, Gustave Roussy Cancer Center, Villejuif, France.; Tayside Cancer Centre, Ninewells Hospital and Medical School, NHS Tayside, Dundee, UK., Karimi M; Oncostat (CESP U1018 INSERM), 'Ligue Contre le Cancer' Labeled Team, Paris-Saclay University, Villejuif, France.; Biostatistics and Epidemiology Department, Gustave Roussy Cancer Centre, Université Paris-Saclay, Villejuif, France., Christou EA; St Johns Institute of Dermatology, King's College London, London, UK., Bizot A; Medical Oncology Department, Gustave Roussy Cancer Center, Villejuif, France., Ropers MA; Clinical Pharmacy Department, Gustave Roussy Cancer Center, Villejuif, France., De-Jesus A; Patient Relationship Coordination, Gustave Roussy Cancer Center, Villejuif, France., Mokdad-Adi M; Medical Oncology Department, Gustave Roussy Cancer Center, Villejuif, France., To THV; Medical Oncology Department, Gustave Roussy Cancer Center, Villejuif, France.; Department of Pneumology and Lung Transplantation, Marie Lannelongue Hospital - Paris Saint Joseph Hospital Group, Le Plessis-Robinson, France., Viansone A; Medical Oncology Department, Gustave Roussy Cancer Center, Villejuif, France., Delaloge S; Medical Oncology Department, Gustave Roussy Cancer Center, Villejuif, France., Besse B; Medical Oncology Department, Gustave Roussy Cancer Center, Villejuif, France., Kfoury M; Medical Oncology Department, Gustave Roussy Cancer Center, Villejuif, France.; Medical Oncology Department, Institut Paoli-Calmettes, Marseille, France.
Jazyk:	angličtina
Zdroj:	Journal of telemedicine and telecare [J Telemed Telecare] 2024 Feb 07, pp. 1357633X241229462. Date of Electronic Publication: 2024 Feb 07.
DOI:	10.1177/1357633X241229462
Abstrakt:	Introduction: During the coronavirus disease 2019 (COVID-19) pandemic, the Gustave Roussy Cancer Center introduced teleconsultation via telephone, as an alternative to face-to-face consultation to reduce patient hospital visits. This study was designed to assess patient and doctor satisfaction with this modality of care in oncology patient care during the period of the pandemic and beyond. Methods: We designed two questionnaires based on validated scores to assess satisfaction from teleconsultation in patients (EORTC OUT-PATSAT 35 and Telemedicine Satisfaction Questionnaire [TSQ] scores) and doctors (Telehealth Usability Questionnaire [TUQ]), and anxiety levels in both groups (anxiety section of the Hospital Anxiety and Depression Scale [HADS], HADS-A). These were electronically sent to patients and doctors with experience of at least one remote consultation during the first wave of the COVID-19 pandemic. Results: 239 patients and 32 doctors were eligible for the analyses. In the patient group, the mean satisfaction scores were 79.5 (SD 18.1) and 74.92 (SD 15.3) for EORTC OUT-PATSAT 35 and TSQ, respectively. In the doctor group, the mean satisfaction scores were 67.1 (SD 12.7) and 64.9 (SD 13.9) for TUQ and TUQ for Skype for Business, respectively. 65.7% of patients and 81.2% of doctors had no/low anxiety. Univariable analyses in patients showed correlation of the EORTC OUT-PATSAT 35 and TSQ scores with anxiety and gender, with lower mean scores in women compared to men. Multivariable analysis showed correlation of the EORTC OUT-PATSAT 35 and TSQ scores to anxiety in both patients and doctors. Conclusions: Teleconsultation via telephone is an acceptable modality of care for oncology patients, with high satisfaction from its implementation during the pandemic reported by patients and doctors. This was consistent across responder groups with different characteristics. An individualized approach to patients should be implemented for the safe and effective use of teleconsultation in oncology beyond the pandemic.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu